These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9543916)

  • 1. Hemoglobin and hematocrit: an analysis of clinical accuracy. Case study of the anemic patient.
    Keen ML
    ANNA J; 1998 Feb; 25(1):83-6. PubMed ID: 9543916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing an anemia management protocol. Case study of the anemic patient.
    Hossli S
    ANNA J; 1997 Dec; 24(6):678-84; quiz 685. PubMed ID: 9444110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis between centrifuged hematocrit and "point-of-care" hemoglobin: impact on erythropoietin dosing.
    Marooney M
    ANNA J; 1998 Oct; 25(5):479-81. PubMed ID: 9887700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of variability in anemia management on hemoglobin outcomes in ESRD.
    Lacson E; Ofsthun N; Lazarus JM
    Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoetin alfa: focus on maintaining a higher, stable, Hct. Case study of the anemic patient.
    Cohen JA; Brattich M
    ANNA J; 1997 Oct; 24(5):574-80; quiz 581. PubMed ID: 9392740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timely correction of anemia at the initiation of dialysis. Case study of the anemic patient.
    Breiterman-White R
    Nephrol Nurs J; 2002 Oct; 29(5):469-72. PubMed ID: 12434453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in hemoglobin levels: clinical implications. Case study of the anemic patient.
    Candela JM; Dutka P; Bennett J; Holland M; Donahue C; Delorme J; Lynn R
    Nephrol Nurs J; 2001 Oct; 28(5):567-70. PubMed ID: 12143433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between hemoglobin and hematocrit levels and hospitalization and survival rates in dialysis patients.
    Brattich M
    Nephrol Nurs J; 2003 Apr; 30(2):231-4. PubMed ID: 12737001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bedside hemoglobinometry in hemodialysis patients: lessons from point-of-care testing.
    Agarwal R; Heinz T
    ASAIO J; 2001; 47(3):240-3. PubMed ID: 11374765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point-of-Care Hemoglobin/Hematocrit Testing: Comparison of Methodology and Technology.
    Maslow A; Bert A; Singh A; Sweeney J
    J Cardiothorac Vasc Anesth; 2016 Apr; 30(2):352-62. PubMed ID: 27013121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRIT-LINE: a noninvasive tool to monitor hemoglobin levels in pediatric hemodialysis patients.
    Garro R; Sutherland S; Bayes L; Alexander S; Wong C
    Pediatr Nephrol; 2015 Jun; 30(6):991-8. PubMed ID: 25854612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia and survival in Thai hemodialysis patients: evidence from national registry data.
    Krairittichai U; Supaporn T; Aimpun P; Wangsiripaisan A; Chaiprasert A; Sakulsaengprapha A; Chittinandana A; Thanachartwet W; Palasawatdhi V; Srangsomwong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S242-7. PubMed ID: 17044478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting anemia management in hemodialysis patients: a single-center experience.
    Spiegel DM; Gitlin M; Mayne T
    Hemodial Int; 2008 Jul; 12(3):336-41. PubMed ID: 18638090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk factors of perioperative hemoglobin and hematocrit drop after intramedullary nailing treatment for intertrochanteric fracture patients.
    Wang J; Wei J; Wang M
    J Orthop Sci; 2015 Jan; 20(1):163-7. PubMed ID: 25366697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The optimal hematocrit--and hemoglobin values in lung diseases].
    Schönhofer B
    Wien Klin Wochenschr; 2001; 113 Suppl 1():6-8. PubMed ID: 15503584
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using noninvasive hemoglobin measurements to estimate measured hemoglobin in a pediatric hemodialysis unit.
    Stavinoha A; Modem V; Quigley R
    Hemodial Int; 2013 Oct; 17 Suppl 1():S7-10. PubMed ID: 24134330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing the anemia of end-stage renal disease after hospitalization.
    Krishnan M; Adams E
    Nephrol Nurs J; 2004; 31(5):541-4. PubMed ID: 15518256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia management protocols and epoetin alfa administration: an algorithm approach. Case study of the anemic patient.
    Aiello J
    Nephrol Nurs J; 2002 Jun; 29(3):297-300. PubMed ID: 12164081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia management practices in peritoneal dialysis patients. Case study of the anemic patient.
    MacCracken MA
    Nephrol Nurs J; 2001 Aug; 28(4):435-8. PubMed ID: 12143466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.